Nautilus Biotechnology, Inc. (NAUT): Shareholders' Equity
$156.97M
As of 2025-12-31
$131.11M
As of 2026-06-30
-20.7%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $156.97M | -24.8% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $208.73M | -21.3% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $265.35M | -15.7% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $314.92M | -13.4% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $363.58M | n/m | 2023-02-23, Balance as of period end |
| 2020-12-31 | -$29.72M | n/a | 2022-02-24, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | 2025-12-31 | $156.97M | -24.8% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $143.70M | +25.4% |
| Seer, Inc. (SEER) | 2025-12-31 | $259.31M | -20.8% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $306.11M | -9.0% |
| Quanterix Corp (QTRX) | 2025-12-31 | $295.73M | -10.4% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $13.73M | -78.3% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $341.74M | -13.6% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $33.21M | -55.9% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $44.42M | +25.6% |
Compare NAUT, MASS, SEER, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗